Trial Profile
Combined administration of lecozotan SR [sustained-release] and citalopram: a double blind, multiple dose study in young healthy subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 12 Aug 2011
Price :
$35
*
At a glance
- Drugs Citalopram (Primary) ; Lecozotan (Primary)
- Indications Alzheimer's disease; Depressive disorders
- Focus Adverse reactions
- Sponsors Wyeth
- 04 Jul 2011 Results published in the European Neuropsychopharmacology.
- 20 Sep 2008 Results presented at ECTRIMS/ACTRIMS/LACTRIMS
- 10 Dec 2007 Status changed from recruiting to completed.